Drug Shortage Report for PMS-IRBESARTAN-HCTZ

Last updated on 2023-04-06 History
Report ID 188954
Drug Identification Number 02328526
Brand name PMS-IRBESARTAN-HCTZ
Common or Proper name IRBESARTAN-HCTZ
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-14
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2023-04-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2023-04-06 French Compare
v1 2023-04-06 English Compare

Showing 1 to 2 of 2